Myriad Genetics (MYGN) Cash from Investing Activities Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -41.81% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 5.31% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -59.07% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 0.00% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 4.07% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -86.97% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -11.88% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -29.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.82% |
| Dec 31, 2025 | 44.76% |
| Sep 30, 2025 | -36.51% |
| Jun 30, 2025 | 16.84% |
| Mar 31, 2025 | 41.43% |
| Dec 31, 2024 | 38.93% |
| Sep 30, 2024 | -70.46% |
| Jun 30, 2024 | -98.47% |
| Mar 31, 2024 | -42.04% |
| Dec 31, 2023 | -34.42% |
| Sep 30, 2023 | -28.99% |
| Jun 30, 2023 | -29.45% |
| Mar 31, 2023 | 14.25% |
| Dec 31, 2022 | 18.14% |
| Sep 30, 2022 | 53.34% |
| Jun 30, 2022 | -67.11% |
| Mar 31, 2022 | -121.51% |
| Dec 31, 2021 | -47.32% |
| Sep 30, 2021 | 44.91% |
| Jun 30, 2021 | -50.19% |